EZH2 and follicular lymphoma: Respectively 7.2% and 21.7% of the cases of follicular lymphoma and DLBCL had “gain-of-function” point mutations that caused a transition from tyrosine to histidine in codon 641 (Tyr641) in the catalytically active SET domain of the EZH2 protein [108].